These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 4015425)
1. Automatic implantable cardioverter-defibrillator: a device for malignant ventricular arrhythmias and sudden death. Emery RW; Huang SK; Copeland JG; Marcus FI Ariz Med; 1985 May; 42(5):288-92. PubMed ID: 4015425 [No Abstract] [Full Text] [Related]
2. [Experience with a transvenous pacemaker-cardioconverter-defibrillator without subcutaneous patch]. Gyöngy T; Merkely B; Tenczer J; Vecsey T; Horkay F; Kalmár I; Matkó I; Solti F; Bodor E Orv Hetil; 1995 Feb; 136(6):299-304. PubMed ID: 7885681 [TBL] [Abstract][Full Text] [Related]
3. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death. Thakor NV; Natarajan A Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992 [TBL] [Abstract][Full Text] [Related]
4. [Implantable defibrillators. Clinical experience]. Mirowski M; Mower MM; Veltri EP; Juanteguy JM Ann Cardiol Angeiol (Paris); 1986 Dec; 35(10):589-95. PubMed ID: 3827149 [TBL] [Abstract][Full Text] [Related]
5. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents]. Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779 [TBL] [Abstract][Full Text] [Related]
6. Recent clinical experience with the automatic implantable cardioverter-defibrillator. Mirowski M; Mower MM; Veltri EP; Juanteguy JM; Reid PR Med Instrum; 1986; 20(5):285-91. PubMed ID: 3784936 [No Abstract] [Full Text] [Related]
7. [The concurrent implantation of a last-generation automatic defibrillator and a 2-chamber pacemaker]. Cesario AS; Palermo P; Baragli D; Amici E; Biancalana G; Gambelli G; Neri R G Ital Cardiol; 1998 Aug; 28(8):878-86. PubMed ID: 9773313 [TBL] [Abstract][Full Text] [Related]
8. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator]. Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352 [TBL] [Abstract][Full Text] [Related]
11. Recent advancements in the management of sudden cardiac death: implantable antiarrhythmic devices. Bissett J; Talley JD J Ark Med Soc; 1995 Jun; 92(1):41-3. PubMed ID: 7615479 [No Abstract] [Full Text] [Related]
12. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S; Kasanuki H J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [TBL] [Abstract][Full Text] [Related]
13. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH; Yee R; Jung W J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117 [TBL] [Abstract][Full Text] [Related]
14. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
15. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. Mirowski M; Reid PR; Mower MM; Watkins L; Gott VL; Schauble JF; Langer A; Heilman MS; Kolenik SA; Fischell RE; Weisfeldt ML N Engl J Med; 1980 Aug; 303(6):322-4. PubMed ID: 6991948 [No Abstract] [Full Text] [Related]
16. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices. Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506 [TBL] [Abstract][Full Text] [Related]
17. Automatic implantable cardioverter defibrillator. Current status. Manolis AS; Rastegar H; Estes NA JAMA; 1989 Sep; 262(10):1362-8. PubMed ID: 2668575 [TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator: present and future indications. Block M; Scheld H; Breithardt G Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176 [TBL] [Abstract][Full Text] [Related]
19. Implantable devices for the treatment of cardiac arrhythmias. Luceri RM; Castellanos A; Myerburg RJ Med Instrum; 1986; 20(5):277-84. PubMed ID: 3784935 [TBL] [Abstract][Full Text] [Related]
20. Automatic implantable cardioverter defibrillator: report of the first two implants in Hawaii. Shen EN; Scully NM; Nakamura DS; Azuma S; Itagaki RK Hawaii Med J; 1989 Jul; 48(7):262-4, 267. PubMed ID: 2777541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]